FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to pharmaceutical compositions that enable to increase the HDL cholesterol level in an individual. Pharmaceutical composition contains at least one methyl cyclodextrin with a degree of molar substitution from 0.05 to 1.5 for treating or preventing diseases that can be treated or prevented by increasing the HDL cholesterol level. Also disclosed is non-therapeutic use of the composition to reduce triglyceride level, and / or to reduce the concentration of free fatty acids, and / or to increase the HDL cholesterol level.
EFFECT: group of inventions provides a drug capable of effectively inducing an increase in HDL cholesterol level in patients.
25 cl, 5 dwg, 4 tbl, 2 ex
